In my years of coding for rheumatology, I am often asked this type of question: “I have a patient who recently came in for a visit. She had two or three diagnoses, was placed on three or four different medications, and we ran one or two labs on her. Does this qualify for a level-four visit?”
Search results for: methotrexate
Wegener’s Granulomatosis Treatment Today
WG has an evolving prognosis and treatment course
Science from our Sisters
Recommended reading from AC&R
Rheum and Race: Where Are We?
It is time to examine the role of race in the care we provide
Stop the Rheumatoid Arthritis (RA) Cascade Early
Early arthritis clinics pioneered diagnosis and treatment to prevent disease progression
Coding Corner Question: March 2008
March’s Coding Challenge
Research Funded by Within Our Reach Highlighted
Five Within Our Reach science investigators provided overviews and updates of their RA research projects to the newly formed Within Our Reach advisory board at its inaugural meeting, held November 8, 2007.
Systemic Vasculitis
Low incidence makes research and diagnosis a challenge
European Beacon for Rheumatology
Josef S. Smolen, MD, led the way for outcomes measures and a scientifically based training program
Myositis Mysteries
Why isn’t my myositis patient getting better?